A human trigeminovascular biomarker for antimigraine drugs: A randomised, double-blind, placebo-controlled, crossover trial with sumatriptan

Author(s):
Ibrahimi, K.; Danser, A.H.J.; Terwindt, G.M.; Meiracker, A.H. van den; MaassenVanDenBrink, A.
Published
2017
Publication type
Article / Letter to editor
Migrainetrigeminovascularantimigraine therapysumatriptanCGRPbiomarker
Date issued
2017-01-31
Language
English
Is part of
Cephalalgia (2017), Vol. 37, no. 1, p. 94-98
hdl
1887/114520
doi
10.1177/0333102416637833